7th Annual Publication and Clinical Trial Transparency
Date: June 20-21, 2018 Location: Amsterdam, The Netherlands In its 7th year, CBI’s Publication and Clinical Trial Transparency creates a bridge…
Date: June 20-21, 2018 Location: Amsterdam, The Netherlands In its 7th year, CBI’s Publication and Clinical Trial Transparency creates a bridge…
The average time to bring a new drug to market is 12 years—assuming it makes it through the rigorous regulatory…
The National Cancer Institute’s Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has…
Patients treated with cemiplimab experienced robust anti-tumor effects Data also presented today at the 2018 ASCO Annual Meeting Cemiplimab…
SOTIO, a biotechnology company owned by the PPF Group, presented results from its Phase II clinical trials evaluating DCVAC, an…
Preliminary data from the first clinical trial of the company’s intracranial ultrasound implant, SonoCloud®, show a good safety profile and…
Danish drugmaker Novo Nordisk said Tuesday its PIONEER 2 study testing oral semaglutide in patients with type 2 diabetes met…
AstraZeneca no longer plans to seek approval of its new respiratory biologic Fasenra in chronic obstructive pulmonary disease (COPD) after the…
Madrigal Pharmaceuticals on Thursday reported highly anticipated results for its Phase 2 non-alcoholic steatohepatitis (NASH) drug MGL-3196, unveiling positive data…